Chinese Severe Brain Injury Trial

Severe Brain Injury Clinical Trial

— CSBIT  

Official title:

Chinese Severe Brain Injury Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06179836
• Other study ID #: CSBIT
• Status: Not yet recruiting
• Start date: January 1, 2024
• Est. completion date: December 31, 2027

Study information

• Verified date: December 2023
• Source: Xuanwu Hospital, Beijing
• Contact: Zhang Yan, MD
• Phone: 13671376710
• Email: zhangylq[@]sina.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Building a Large Chinese Cohort(Chinese Severe brain injury Trial）

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 3000
• Est. completion date: December 31, 2027
• Est. primary completion date: December 31, 2026
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• a clear cause of brain injury

• disorders of consciousness, GCS=12

• within six months of onset

Exclusion Criteria:

• not applicable

Related Conditions & MeSH terms

• Brain Injuries
• Severe Brain Injury
• Wounds and Injuries

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Xuanwu Hospital, Beijing

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Glasgow Outcome Scale	The unabbreviated scale title is Glasgow Outcome Scale. GOS includes a score of 1-5, with the higher the score, the better the prognosis.	6 months after severe Brain Injury
Secondary	Glasgow Outcome Scale	The unabbreviated scale title is Glasgow Outcome Scale. GOS includes a score of 1-5, with the higher the score, the better the prognosis.	3 months and 12 months after severe Brain Injury